Home › Funds › SEVEN GRAND MANAGERS, LLC › APGE

SEVEN GRAND MANAGERS, LLC position in APGE

APOGEE THERAPEUTICS INC

SEVEN GRAND MANAGERS, LLC reported holding 100,000 shares of APGE (APOGEE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$13.3M, representing 0.53% of its reported portfolio and ranking #43 among its reported holdings. SEVEN GRAND MANAGERS, LLC has disclosed APGE holdings in 4 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)100.00K sh
Reported value held$13.27M
Portfolio Weight0.53%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SEVEN GRAND MANAGERS, LLC's APGE position evolved

SEVEN GRAND MANAGERS, LLC first disclosed a stake in APGE in Q3 2023 at 48,198 shares (US$1.0M). The position peaked in Q2 2026 at 100,000 shares, worth US$13.3M. Across 4 filings, SEVEN GRAND MANAGERS, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 100,000 shares valued at US$13.3M. Notable position changes include a 100% increase in Q1 2026.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 48.20K $1.03M New
Q4 2025 50.00K $3.77M New
Q1 2026 100.00K $8.42M Add
Q2 2026 100.00K $13.27M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About APGE and 13F data

APGE (APOGEE THERAPEUTICS INC) is a company whose sector is not yet classified in our data. 60 other funds we track also report a position in APGE — the largest reported positions include Venrock Adviser, LLC (US$1.13B), HBK INVESTMENTS L P (US$378.3M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$231.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding APGE

All APGE fund holders →

FAQ

How long has SEVEN GRAND MANAGERS, LLC held APGE?

SEVEN GRAND MANAGERS, LLC has disclosed APGE holdings in 4 of the last 12 reported quarters, going back to Q3 2023.

What is SEVEN GRAND MANAGERS, LLC's current position in APGE?

As of Q2 2026, SEVEN GRAND MANAGERS, LLC holds 100.00K shares of APGE (APOGEE THERAPEUTICS INC), valued at $13.27M, representing 0.53% of its reported portfolio and ranking #43.

Has SEVEN GRAND MANAGERS, LLC been buying or selling APGE?

In the latest 13F filing (Q2 2026), SEVEN GRAND MANAGERS, LLC held unchanged its position in APGE. The position peaked in Q2 2026 at 100.00K shares.

Which other funds hold APGE?

Other major institutional holders of APGE include Venrock Adviser, LLC, HBK INVESTMENTS L P, DRIEHAUS CAPITAL MANAGEMENT LLC, among 60 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.